Restraint use and risky driving behaviors across drug types and drug and alcohol combinations for drivers involved in a fatal motor vehicle collision on U.S. roadways

Injury Epidemiology - Tập 3 - Trang 1-9 - 2016
Chang Liu1, Yanlan Huang2, Joyce C. Pressley1,3,4
1Columbia University Mailman School of Public Health, Department of Epidemiology, New York, USA
2Columbia University Department of Biostatistics, New York, USA
3Columbia University Mailman School of Public Health Departments of Epidemiology and Health Policy and Management, New York, USA
4Center for Injury Epidemiology and Prevention at Columbia University Mailman School of Public Health, New York, USA

Tóm tắt

While driving impaired is a well-recognized risk factor for motor vehicle (MV) crash, recent trends in recreational drug use and abuse may pose increased threats to occupant safety. This study examines mechanisms through which drug and/or alcohol combinations contribute to fatal MV crash. The Fatality Analysis Reporting System (FARS) for 2008–2013 was used to examine drugs, alcohol, driver restraint use, driver violations/errors and other behaviors of drivers of passenger vehicles who were tested for both alcohol and drugs (n = 79,932). Statistical analysis was based on Chi-square tests and multivariable logistic regression. Associations of restraint use and other outcomes with alcohol and drug use were measured by estimated odds ratios (ORs) and 95 % confidence intervals (95 % CIs). More than half (54.8 %) of the study population were positive for drugs or alcohol at the time of crash. Approximately half of drivers were belted, but this varied from 67.1 % (unimpaired) to 33.0 % (drugs plus alcohol). Compared to the unimpaired, the odds of a driver being unbelted varied: alcohol and cannabis (OR 3.70, 95 % CI 3.44–3.97), alcohol only (3.50,3.36–3.65), stimulants (2.13,1.91–2.38), depressants (2.09,1.89–2.31), narcotics (1.84,1.67–2.02) and cannabis only (1.55,1.43–1.67). Compared to belted drivers, unbelted drivers were over 4 times more likely to die. Driving violations varied across drug/drug alcohol combinations. Speed-related violations were higher for drivers positive for stimulants, alcohol, cannabis, and cannabis plus alcohol, with a more than two fold increase for alcohol and cannabis (2.36, 2.05, 2.71). Mechanisms through which drugs, alcohol and substance combinations produce increased risks to occupant safety include lowered restraint use and increases in risky driving behaviors, including speeding, lane, passing, turning and signal/sign violations.

Tài liệu tham khảo

Anderson DM, Rees DI. The legalization of recreational marijuana: how likely is the worst-case scenario? J Policy Anal Manage. 2014;33(1):221–32. Barkley RA, Cox D. A review of driving risks and impairments associated with attention-deficit/hyperactivity disorder and the effects of stimulant medication on driving performance. J Saf Res. 2007;38(1):113–28. Bédard M, Dubois S, Weaver B. The impact of cannabis on driving. Can J Public Health. 2007;98(1):6–11. Bogstrand ST, Larsson M, Holtan A, Staff T, Vindenes V, Gjerde H. Associations between driving under the influence of alcohol or drugs, speeding and seatbelt use among fatally injured car drivers in Norway. Accid Anal Prev. 2015;78:14–9. Brady JE, Li G. Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999–2010. Am J Epidemiol. 2014;179(6):692–9. Calhoun VD, Pekar JJ, Pearlson GD. Alcohol intoxication effects on simulated driving: exploring alcohol-dose effects on brain activation using functional MRI. Neuropsychopharmacology. 2004;29(11):2097-17. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis. 2000;188(4):230–4. Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn J, Robertson MD, et al. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accid Anal Prev. 2004;36(2):239–48. Dubois S, Mullen N, Weaver B, Bédard M. The combined effects of alcohol and cannabis on driving: impact on crash risk. Forensic Sci Int. 2015;248:94–100. FARS. FARS Analytical User’s Manual 1975 – 2013: U. S. Department of Transportation National Highway Traffic Safety Administration. 2014. Gates J, Dubois S, Mullen N, Weaver B, Bédard M. The influence of stimulants on truck driver crash responsibility in fatal crashes. Forensic Sci Int. 2013;228(1):15–20. Giovanardi D, Castellana CN, Pisa S, Poppi B, Pinetti D, Bertolini A, et al. Prevalence of abuse of alcohol and other drugs among injured drivers presenting to the emergency department of the University Hospital of Modena, Italy. Drug Alcohol Depend. 2005;80(1):135–8. Johnson MB, Kelley-Baker T, Voas RB, Lacey JH. The prevalence of cannabis-involved driving in California. Drug Alcohol Depend. 2012;123(1):105–9. Kurzthaler I, Hummer M, Miller C, Sperner-Unterweger B, Günther V, Wechdorn H, et al. Effect of cannabis use on cognitive functions and driving ability. J Clin Psychiatry. 1999;60(6):395–9. Li G, Brady JE, Chen Q. Drug use and fatal motor vehicle crashes: a case-control study. Accid Anal Prev. 2013;60:205–10. Longo MC, Hunter CE, Lokan RJ, White JM, White MA. The prevalence of alcohol, cannabinoids, benzodiazepines and stimulants amongst injured drivers and their role in driver culpability: part ii: the relationship between drug prevalence and drug concentration, and driver culpability. Accid Anal Prev. 2000;32(5):623–32. Maull KI, Kinning LS, Hickman JK. Culpability and accountability of hospitalized injured alcohol-impaired drivers: a prospective study. JAMA. 1984;252(14):1880–3. Mura P, Kintz P, Ludes B, Gaulier J-M, Marquet P, Martin-Dupont S, et al. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int. 2003;133(1):79–85. Quinlan KP, Brewer RD, Siegel P, Sleet DA, Mokdad AH, Shults RA, et al. Alcohol-impaired driving among US adults, 1993–2002. Am J Prev Med. 2005;28(4):346–50. Ramaekers JG, Robbe H, O’Hanlon J. Marijuana, alcohol and actual driving performance. Hum Psychopharmacol Clin Exp. 2000;15(7):551–8. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend. 2004;73(2):109–19. Reguly P, Dubois S, Bedard M. Examining the impact of opioid analgesics on crash responsibility in truck drivers involved in fatal crashes. Forensic Sci Int. 2014;234:154–61. Romano E, Pollini RA. Patterns of drug use in fatal crashes. Addiction. 2013;108(8):1428–38. SAMHSA. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville: Substance Abuse and Mental Health Services Administration; 2014. Contract No.: HHS Publication No. (SMA) 14-4863. Silber BY, Papafotiou K, Croft RJ, Ogden E, Swann P, Stough C. The effects of dexamphetamine on simulated driving performance. Psychopharmacology. 2005;179(3):536–43. Soderstrom CA, Dischinger PC, Ho SM, Soderstrom MT. Alcohol use, driving records, and crash culpability among injured motorcycle drivers. Accid Anal Prev. 1993;25(6):711–6. Timby N, Sjögren H, Björnstig U, Eriksson A. Crash responsibility versus drug and alcohol use among fatally injured and hospitalized motor vehicle drivers in Sweden. Alcohol Clin Exp Res. 1998;22(8):1838–41. West R, Wilding J, French D, Kemp R, Irving A. Effect of low and moderate doses of alcohol on driving hazard perception latency and driving speed. Addiction. 1993;88(4):527–32.